Ocular Therapeutix (OCUL) Interest Coverage Ratio (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.45% |
| Dec 31, 2025 | -7.64% |
| Sep 30, 2025 | -2.04% |
| Jun 30, 2025 | -4.70% |
| Mar 31, 2025 | -31.55% |
| Dec 31, 2024 | -14.13% |
| Sep 30, 2024 | -4.61% |
| Jun 30, 2024 | -74.75% |
| Mar 31, 2024 | -61.58% |
| Dec 31, 2023 | 13.87% |
| Sep 30, 2023 | 45.72% |
| Jun 30, 2023 | 18.99% |
| Mar 31, 2023 | -21.67% |
| Dec 31, 2022 | 12.57% |
| Sep 30, 2022 | -2.09% |
| Jun 30, 2022 | -10.82% |
| Mar 31, 2022 | 1.37% |
| Dec 31, 2021 | 8.79% |
| Sep 30, 2021 | 3.64% |
| Jun 30, 2021 | -1.47% |
| Mar 31, 2021 | -44.98% |
| Dec 31, 2020 | -1.75% |
| Sep 30, 2020 | 22.64% |
| Jun 30, 2020 | -3.77% |
| Mar 31, 2020 | 14.19% |
| Dec 31, 2019 | 15.42% |
| Sep 30, 2019 | -5.60% |
| Jun 30, 2019 | 31.25% |
| Mar 31, 2019 | 58.21% |
| Dec 31, 2018 | -32.25% |
| Sep 30, 2018 | -17.22% |
| Jun 30, 2018 | -7.68% |
| Mar 31, 2018 | -6.68% |
| Dec 31, 2017 | 16.15% |
| Sep 30, 2017 | 21.02% |
| Jun 30, 2017 | -10.77% |
| Mar 31, 2017 | -18.57% |
| Dec 31, 2016 | -37.59% |
| Sep 30, 2016 | 18.39% |
| Jun 30, 2016 | -5.69% |
| Mar 31, 2016 | 0.17% |
| Dec 31, 2015 | 8.50% |
| Sep 30, 2015 | -15.69% |
| Jun 30, 2015 | -68.90% |
| Mar 31, 2015 | 24.04% |
| Dec 31, 2014 | -12.75% |
| Sep 30, 2014 | 28.91% |
| Jun 30, 2014 | 85.42% |
| Mar 31, 2014 | -322.45% |
| Dec 31, 2013 | -2.82% |
| Sep 30, 2013 | -30.81% |